Neurology Perspective

 
 

  • Tragedy, Hope, and a Medical Mystery: 'The Covenant of Water'   Dr Eric Topol and Dr Robert Harrington interview Dr Abraham Verghese about his fiction writing methods and Oprah's enthusiasm for his latest novel.
  • Transplant Centers Often Skip the Top Spot on the Kidney Waitlist   How donor kidneys are allocated to waiting patients isn't as straightforward as it might seem.
  • Game-Changing Alzheimer’s Research: The Latest on Biomarkers Dr Bradford Dickerson discusses the current framework for defining Alzheimer’s disease biologically, and the potential for emerging plasma biomarkers.
  • From ECCMID: New Anti-Viral and Bacterial Drugs of Interest   Infectious disease expert Dr Paul Auwaerter discusses news from ECCMID, including data on invasive group A streptococcus infections, and the new drugs ensitrelvir, gepotidacin, and sulbactam-durlobactam.
  • Medscape Physician Assistant Compensation Report 2023 Physician assistants (PAs) seem increasingly dissatisfied with their compensation, even though it rose last year. Gender and age made a difference, with male and older PAs earning more on average.
  • Jun 02, 2023 This Week in Cardiology   Listener feedback on the most important study in a decade, MONITOR-HF, a flawed paper and analysis, and the tension between pathos and logos are the topics John Mandrola, MD discusses in this week's podcast.
  • Is the Field of Electrophysiology Stuck? The 2023 Heart Rhythm Society meeting featured hot topics such as pulsed-field ablation and late-breaking "trials" on conduction system pacing, but the data gave this electrophysiologist pause.
  • COVID Boosters Effective, but Not for Long   Dr F. Perry Wilson explains a unique study design that helps answer questions about the effectiveness of COVID booster vaccines.
  • May 26 2023 This Week in Cardiology   An HRS meeting recap, Impella failure, sacubitril/valsartan, the purpose of trials, and a major breakthrough in evidence generation are the topics discussed by John Mandrola, MD in this week's podcast.
  • A Glimpse of Hope in Alzheimer's Disease?   Neurologist Hans-Christoph Diener reviews the data on new monoclonal therapies that bring hope to the treatment of Alzheimer's disease.
  • Alzheimer's Disease Highlights From AAN 2023   Highlights in Alzheimer's disease (AD) presented at AAN 2023 focus on amyloid-lowering therapies in early AD, 12-month results of ALZ-801, and ALZ-NET, a national registry that benefits AD research.
  • To Cease or Not to Cease Anticoagulation After AF Ablation The debate around anticoagulation post-AF ablation revolves around striking the delicate balance between preventing strokes and minimizing bleeding risks. In comparing study outcomes, we will explore the ongoing investigation of how to optimally treat patients.
  • Medscape Neurologist Compensation Report 2023 Is neurologists' income trending in the right direction? Do they feel fairly paid and would they choose a medical career again? Our 2023 Neurologist Compensation Report gives the answers.
  • Ketamine, Pain, and Depression: A Special Connection   Ketamine may be a potent analgesic, but its effects on chronic pain may have more to do with its antidepressant effects, according to a recent study. F. Perry Wilson comments.
  • S2 Episode 4: Schizophrenia, Clinical High-risk Syndrome, and Psychosis   Drs John M. Kane and Scott W. Woods discuss clinical high-risk syndrome and schizophrenia, including assessment methods, interventions, and risk indicators for future psychosis.
  • Prior-Authorization Woes? These Tools May Change the Game   Alok S. Patel, MD, discusses prior authorizations and the potential use of artificial intelligence.
  • May 19 2023 This Week in Cardiology   When to use an ICD, risk stratification for HCM, blending EP and structural cardiology to improve care in post-TAVI patients, and hsTroponins are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Best & Worst Places to Practice 2023 Check out our 2023 choices for the best and worst communities, based on such factors as income, malpractice climate, lifestyle, and health indicators.
  • Top 5 Movement Disorders Highlights From AAN 2023   Kathrin LaFaver discusses the movement disorders presentations that piqued her interest at the 2023 American Academy of Neurology meeting with fellow neurologist Indu Subramanian.
  • What to Expect in the New Concussion Guidelines   Andrew N. Wilner, MD, and Shae Datta, MD, discuss recent developments in sports neurology.